| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
32,935 |
28,580 |
$10.71M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,064 |
25,334 |
$5.14M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,546 |
5,135 |
$2.96M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,239 |
14,175 |
$2.52M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,527 |
5,051 |
$1.74M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,670 |
1,487 |
$1.16M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
998 |
896 |
$881K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,204 |
8,130 |
$585K |
| C1776 |
Joint device (implantable) |
434 |
377 |
$517K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,087 |
2,722 |
$437K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,116 |
3,851 |
$354K |
| G0378 |
Hospital observation service, per hour |
14,681 |
7,426 |
$279K |
| 80053 |
Comprehensive metabolic panel |
57,260 |
46,471 |
$232K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,819 |
2,606 |
$199K |
| 27447 |
|
37 |
26 |
$183K |
| 49083 |
|
553 |
301 |
$149K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,686 |
8,352 |
$140K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
92 |
89 |
$102K |
| 36430 |
|
569 |
441 |
$102K |
| 29580 |
|
4,171 |
1,399 |
$90K |
| 47562 |
|
27 |
26 |
$80K |
| 70496 |
|
149 |
142 |
$77K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,403 |
3,457 |
$58K |
| 93971 |
|
1,861 |
1,690 |
$52K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,401 |
2,737 |
$50K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
115 |
97 |
$49K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,727 |
2,361 |
$45K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,776 |
2,492 |
$45K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
260 |
248 |
$44K |
| 72131 |
|
165 |
150 |
$43K |
| 49650 |
|
12 |
12 |
$41K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
34,570 |
27,222 |
$39K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,063 |
23,065 |
$37K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
603 |
536 |
$35K |
| 29445 |
|
406 |
145 |
$32K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
23,065 |
17,996 |
$31K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
111 |
101 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,631 |
3,260 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,710 |
1,126 |
$25K |
| 74174 |
|
29 |
28 |
$25K |
| 71250 |
|
385 |
359 |
$22K |
| 95811 |
|
28 |
26 |
$17K |
| 93970 |
|
101 |
90 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
323 |
301 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,189 |
5,674 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,903 |
4,531 |
$16K |
| 96376 |
|
9,482 |
6,098 |
$15K |
| 70486 |
|
176 |
157 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,798 |
1,661 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,139 |
6,070 |
$10K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
40 |
39 |
$9K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
214 |
123 |
$9K |
| 80320 |
|
4,757 |
4,393 |
$9K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
104 |
100 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,702 |
4,052 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
6,120 |
5,497 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,830 |
6,644 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,911 |
17,111 |
$7K |
| 87075 |
|
541 |
408 |
$6K |
| C1781 |
Mesh (implantable) |
128 |
125 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,518 |
6,899 |
$6K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
12 |
$5K |
| 85610 |
|
25,671 |
20,032 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
91 |
82 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
59,448 |
48,546 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
24,963 |
21,703 |
$4K |
| 36591 |
|
2,259 |
904 |
$4K |
| 10060 |
|
28 |
28 |
$4K |
| 36416 |
|
5,450 |
3,458 |
$4K |
| 93976 |
|
571 |
541 |
$4K |
| 76830 |
Ultrasound, transvaginal |
264 |
259 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
129 |
119 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
155 |
131 |
$3K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
12 |
12 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,595 |
4,307 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,144 |
846 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
681 |
653 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,106 |
1,955 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,004 |
12,646 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 70498 |
|
187 |
178 |
$2K |
| J3490 |
Unclassified drugs |
29,180 |
12,727 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,262 |
10,293 |
$2K |
| C1769 |
Guide wire |
998 |
864 |
$1K |
| 81025 |
|
4,061 |
3,859 |
$1K |
| 87040 |
|
9,506 |
4,566 |
$1K |
| 84484 |
|
25,610 |
15,164 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,057 |
6,403 |
$1K |
| 84703 |
|
6,701 |
6,269 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,501 |
6,720 |
$1K |
| 73562 |
|
1,700 |
1,473 |
$1K |
| 87631 |
|
903 |
856 |
$1K |
| 73610 |
|
1,237 |
1,077 |
$975.68 |
| 73630 |
|
1,409 |
1,268 |
$964.88 |
| 82947 |
|
22,265 |
10,176 |
$896.63 |
| 81001 |
|
16,149 |
14,333 |
$890.42 |
| 83690 |
|
16,666 |
14,631 |
$796.94 |
| 73130 |
|
986 |
888 |
$698.32 |
| 73502 |
|
1,016 |
888 |
$628.44 |
| 96367 |
|
1,213 |
1,083 |
$545.66 |
| 84702 |
|
3,019 |
2,820 |
$541.08 |
| 86923 |
|
452 |
243 |
$538.31 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,249 |
3,115 |
$532.30 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,014 |
986 |
$504.66 |
| 83605 |
|
12,506 |
9,681 |
$502.28 |
| 73030 |
|
1,474 |
1,312 |
$473.47 |
| 83880 |
|
7,310 |
6,442 |
$470.70 |
| 72170 |
|
306 |
268 |
$467.73 |
| 87186 |
|
3,338 |
2,773 |
$441.25 |
| 83735 |
|
16,287 |
12,671 |
$434.91 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
497 |
483 |
$425.47 |
| 81003 |
|
7,784 |
7,153 |
$420.87 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
460 |
447 |
$390.44 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,527 |
762 |
$387.50 |
| 82803 |
|
648 |
534 |
$378.15 |
| 76770 |
|
14 |
14 |
$372.86 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,221 |
1,471 |
$364.80 |
| 80329 |
|
589 |
519 |
$330.20 |
| A9270 |
Non-covered item or service |
62,796 |
9,453 |
$286.16 |
| 76801 |
|
53 |
49 |
$271.86 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
302 |
281 |
$261.93 |
| 85027 |
|
6,749 |
5,098 |
$251.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12,027 |
10,085 |
$232.72 |
| 90715 |
|
1,017 |
970 |
$222.43 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,438 |
1,470 |
$221.34 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
588 |
571 |
$218.71 |
| 87088 |
|
6,398 |
5,373 |
$207.18 |
| 85730 |
|
5,020 |
4,487 |
$206.11 |
| 99152 |
|
767 |
702 |
$201.51 |
| 87070 |
|
1,930 |
1,396 |
$190.07 |
| 86850 |
|
3,395 |
2,903 |
$173.15 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,179 |
10,341 |
$170.48 |
| 94760 |
|
4,451 |
2,021 |
$166.17 |
| 87077 |
|
3,985 |
3,121 |
$162.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,232 |
5,768 |
$155.53 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
57 |
54 |
$152.73 |
| 73110 |
|
394 |
347 |
$152.30 |
| 82565 |
|
775 |
667 |
$147.12 |
| 84132 |
|
2,417 |
1,588 |
$146.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,760 |
8,050 |
$136.68 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
28,234 |
10,654 |
$135.28 |
| 80061 |
Lipid panel |
492 |
434 |
$121.37 |
| 85014 |
|
1,826 |
1,333 |
$106.24 |
| 85379 |
|
2,160 |
2,005 |
$105.02 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
101 |
92 |
$100.67 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,272 |
1,828 |
$100.29 |
| G0379 |
Direct admission of patient for hospital observation care |
129 |
114 |
$96.22 |
| 72100 |
|
129 |
118 |
$92.98 |
| 85018 |
|
2,056 |
1,479 |
$87.12 |
| 97161 |
|
2,351 |
2,034 |
$85.95 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,364 |
1,153 |
$69.59 |
| 85055 |
|
1,891 |
1,314 |
$68.46 |
| 82550 |
|
3,767 |
3,224 |
$65.86 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,107 |
1,008 |
$63.38 |
| 86140 |
|
3,095 |
2,737 |
$59.85 |
| J1815 |
Injection, insulin, per 5 units |
4,528 |
2,271 |
$56.24 |
| 84439 |
|
840 |
733 |
$52.71 |
| 74018 |
|
346 |
313 |
$49.26 |
| 82728 |
|
320 |
274 |
$46.58 |
| 87205 |
|
2,032 |
1,465 |
$46.48 |
| 93041 |
|
314 |
268 |
$41.05 |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,760 |
2,120 |
$40.14 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,080 |
1,020 |
$38.34 |
| 97116 |
|
2,180 |
1,429 |
$36.59 |
| 82010 |
|
269 |
220 |
$36.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,024 |
3,190 |
$29.78 |
| 88342 |
|
198 |
161 |
$29.56 |
| 85652 |
|
1,617 |
1,415 |
$29.21 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,200 |
3,151 |
$28.12 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,481 |
4,765 |
$27.51 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
3,324 |
2,769 |
$27.40 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,846 |
3,419 |
$27.00 |
| J2060 |
Injection, lorazepam, 2 mg |
3,368 |
2,828 |
$26.68 |
| 84145 |
|
373 |
353 |
$26.30 |
| 86901 |
|
3,704 |
3,219 |
$25.41 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,383 |
689 |
$25.30 |
| 86900 |
|
3,532 |
3,057 |
$22.78 |
| 96368 |
|
263 |
237 |
$22.78 |
| J2704 |
Injection, propofol, 10 mg |
8,219 |
7,457 |
$18.81 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
961 |
760 |
$18.48 |
| 82140 |
|
1,247 |
1,104 |
$15.20 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,567 |
961 |
$15.18 |
| 97535 |
Self-care/home management training, each 15 minutes |
1,568 |
1,036 |
$14.82 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
494 |
460 |
$14.66 |
| 73590 |
|
29 |
27 |
$12.48 |
| 12001 |
|
40 |
40 |
$12.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
165 |
148 |
$10.40 |
| 99153 |
Mod sedat endo service >5yrs |
663 |
606 |
$10.09 |
| J7999 |
Compounded drug, not otherwise classified |
544 |
490 |
$7.24 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,599 |
527 |
$6.97 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,632 |
1,357 |
$6.63 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
124 |
107 |
$6.43 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
802 |
341 |
$6.32 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,153 |
1,478 |
$5.93 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,123 |
1,485 |
$5.06 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
230 |
183 |
$4.08 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,081 |
565 |
$2.92 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,343 |
1,212 |
$1.94 |
| 84100 |
|
2,490 |
1,860 |
$1.36 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,767 |
1,589 |
$1.34 |
| J7050 |
Infusion, normal saline solution, 250 cc |
206 |
122 |
$0.67 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,917 |
6,252 |
$0.47 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
106 |
101 |
$0.01 |
| Q0247 |
Injection, sotrovimab, 500 mg |
92 |
89 |
$0.01 |
| 83540 |
|
78 |
64 |
$0.00 |
| 85520 |
|
203 |
172 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
380 |
250 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
170 |
138 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
797 |
572 |
$0.00 |
| 89051 |
|
206 |
114 |
$0.00 |
| 94664 |
|
586 |
419 |
$0.00 |
| 51701 |
|
262 |
224 |
$0.00 |
| 84520 |
|
234 |
202 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
426 |
386 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
479 |
381 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,043 |
951 |
$0.00 |
| 84295 |
|
208 |
190 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
104 |
95 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
185 |
179 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
245 |
237 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
465 |
268 |
$0.00 |
| 84466 |
|
64 |
51 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
18 |
13 |
$0.00 |
| 36600 |
|
47 |
44 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
125 |
91 |
$0.00 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
53 |
44 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
40 |
39 |
$0.00 |
| 87102 |
|
16 |
13 |
$0.00 |
| 76937 |
|
43 |
37 |
$0.00 |
| 51702 |
|
50 |
41 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
12 |
12 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
19 |
13 |
$0.00 |
| 88304 |
|
559 |
513 |
$0.00 |
| 97165 |
|
710 |
619 |
$0.00 |
| 82435 |
|
153 |
145 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
201 |
196 |
$0.00 |
| 94761 |
|
72 |
53 |
$0.00 |
| 87206 |
|
40 |
24 |
$0.00 |
| 73560 |
|
40 |
25 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
123 |
80 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,221 |
1,065 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
99 |
91 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
262 |
245 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
567 |
415 |
$0.00 |
| 74021 |
|
69 |
61 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
14 |
12 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
94 |
90 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
157 |
142 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
200 |
183 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
14 |
13 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
147 |
134 |
$0.00 |
| 90686 |
|
116 |
107 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
510 |
400 |
$0.00 |
| 82553 |
|
117 |
99 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
140 |
117 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
12 |
12 |
$0.00 |
| 82330 |
|
31 |
28 |
$0.00 |
| 88307 |
|
158 |
140 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$0.00 |
| 12002 |
|
13 |
13 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
26 |
14 |
$0.00 |
| 82607 |
|
14 |
12 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
32 |
31 |
$0.00 |
| 87116 |
|
13 |
12 |
$0.00 |
| 70544 |
|
24 |
24 |
$0.00 |
| 83615 |
|
14 |
12 |
$0.00 |
| 71101 |
|
36 |
36 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
18 |
12 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
12 |
12 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
31 |
26 |
$0.00 |